Area of research
Pulmonary and Respiratory Medicine · Molecular Biology
Research interest
Research focused on Taurine and Cancer research, with related work in Lung cancer, Gefitinib, PI3K/AKT/mTOR pathway. Notable publications include 'The key role of sphingolipid metabolism in cancer: New therapeutic targets, diagnostic and prognostic values, and anti-tumor immunotherapy resistance', 'Honokiol Induces Apoptosis, G1 Arrest, and Autophagy in KRAS Mutant Lung Cancer Cells', and 'Down-regulating Nrf2 by tangeretin reverses multiple drug resistance to both chemotherapy and EGFR tyrosine kinase inhibitors in lung cancer'.
Taurine and proline promote lung tumour growth by co-regulating Azgp1/mTOR signalling pathway
Serum taurine affects lung cancer progression by regulating tumor immune escape mediated by the immune microenvironment
Taurine and proline promote lung tumour growth by co-regulating Azgp1/mTOR signalling pathway
The key role of sphingolipid metabolism in cancer: New therapeutic targets, diagnostic and prognostic values, and anti-tumor immunotherapy resistance
Down-regulating Nrf2 by tangeretin reverses multiple drug resistance to both chemotherapy and EGFR tyrosine kinase inhibitors in lung cancer
An analgesic peptide H-20 attenuates chronic pain via the PD-1 pathway with few adverse effects
Novel clinical biomarkers in blood and pleural effusion for diagnosing patients with tuberculosis distinguishing from malignant tumor
Honokiol Induces Apoptosis, G1 Arrest, and Autophagy in KRAS Mutant Lung Cancer Cells
Abstract 3034: Overcoming gefitinib resistance in non-small-cell lung cancer by inducing epidermal growth factor receptor (EGFR) degradation via methionine 790 oxidation